Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Diplomat Pharmacy, Inc. | a17-1189_1ex32d1.htm |
| EX-31.2 - EX-31.2 - Diplomat Pharmacy, Inc. | a17-1189_1ex31d2.htm |
| EX-31.1 - EX-31.1 - Diplomat Pharmacy, Inc. | a17-1189_1ex31d1.htm |
| EX-23 - EX-23 - Diplomat Pharmacy, Inc. | a17-1189_1ex23.htm |
| EX-21 - EX-21 - Diplomat Pharmacy, Inc. | a17-1189_1ex21.htm |
| EX-10.25 - EX-10.25 - Diplomat Pharmacy, Inc. | a17-1189_1ex10d25.htm |
| EX-10.24 - EX-10.24 - Diplomat Pharmacy, Inc. | a17-1189_1ex10d24.htm |
| EX-10.21 - EX-10.21 - Diplomat Pharmacy, Inc. | a17-1189_1ex10d21.htm |
| 10-K - 10-K - Diplomat Pharmacy, Inc. | a17-1189_110k.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Diplomat Pharmacy, Inc. on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robin Johnson, Vice President — Finance of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: March 8, 2017 |
|
|
|
|
|
|
|
|
By: |
/s/ ROBIN JOHNSON |
|
|
|
Robin Johnson |
|
|
|
Vice President, Finance |
|
|
|
(Principal Financial Officer) |